AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
fi 5 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Enloe Medical Center, Chico
UC San Diego Health System - Encinitas, Encinitas
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
fi 20 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

University of California San Diego Health, San Diego

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 fi ol · Dhiroota · Haaromfame 29-Ful-2026 · NCT07569926

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 90 · Dhiroota · Haaromfame 29-Ful-2026 · NCT07185165

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Om Research, San Diego

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 40 hanga 75 · Dhiroota · Haaromfame 28-Ful-2026 · NCT07543757

Precision-Based Genomics in Prostate Cancer

University of California San Diego, La Jolla
University of California San Francisco, San Francisco

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 hanga 120 · Dhiroota · Haaromfame 28-Ful-2026 · NCT04706663

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

University of California San Diego, Moores Cancer Center, La Jolla

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06801236

DESTINY-PANTUMOUR04

Research Site, San Diego

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site, Los Angeles

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 hanga 130 · Dhiroota · Haaromfame 25-Ful-2026 · NCT07181161

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location), Beverly Hills
fi 20 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 24-Ful-2026 · NCT07028853

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

START Los Angeles, Los Angeles

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 24-Ful-2026 · NCT07719361

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

VA Greater LA Healthcare System, Los Angeles
VA Palo Alto Health Care System, Palo Alto
Stanford University Medical Center, Palo Alto
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06780670

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

City of Hope National Medical Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Duarte
Providence Saint Jude Medical Center, Fullerton
fi 3 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Univ Cali Irvine ALS Neuromuscular, Orange
Stanford University Medical Center, Palo Alto
Sansum Clinic, Santa Barbara

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, La Jolla
Research Site, La Jolla
Research Site, Los Angeles
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 18-Ful-2026 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dhiroota · Haaromfame 17-Ful-2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

City of Hope Comprehensive Cancer Center ( Site 0049), Duarte
City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
Moores Cancer Center ( Site 0010), La Jolla
fi 5 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 17-Ful-2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

GSK Investigational Site, La Jolla

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Dhiroota · Haaromfame 16-Ful-2026 · NCT07332455

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Hoag Memorial Hospital Presbyterian, Irvine

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 15-Ful-2026 · NCT07581184

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

USNC, Mountain View
Tri Valley Urology, Murrieta
University of California San Francisco, San Francisco

Namoota walitti qabaa jira

Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ful-2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Urology Group of Southern California, Los Angeles
Greater Los Angeles VA Medical Center, Los Angeles
UC Irvine Health, Orange
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT06056830

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

University of California, San Francisco, San Francisco

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05766371

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Kaiser Permanente-Deer Valley Medical Center, Antioch
Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
fi 34 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

UCI Health Chao Family Comprehensive Cancer Center, Orange
Investigational Site Number: 403, Palo Alto

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05997615

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06440005

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

Duarte Cancer Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

Namoota walitti qabaa jira

Umuriin 18 fi ol · Dhiroota · Haaromfame 09-Ful-2026 · NCT05804318

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.